1 study found for:    23574119 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma
Condition: Non Hodgkin's Lymphoma
Intervention: Drug: EPOCH-R

Indicates status has not been verified in more than two years